Published in PLoS Genet on April 20, 2017
Therapeutic strategies for spinal muscular atrophy: SMN and beyond. Dis Model Mech (2017) 0.75
Identification and characterization of a spinal muscular atrophy-determining gene. Cell (1995) 17.41
A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A (1999) 7.60
The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell (1997) 5.57
The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet (2000) 5.38
The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell (1997) 5.28
A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet (1999) 5.09
Synaptic mitochondria are critical for mobilization of reserve pool vesicles at Drosophila neuromuscular junctions. Neuron (2005) 4.87
Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc Natl Acad Sci U S A (1997) 4.70
A mouse model for spinal muscular atrophy. Nat Genet (2000) 4.37
A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat Neurosci (2009) 3.89
Mitochondria and neuronal survival. Physiol Rev (2000) 3.56
Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol (2003) 3.40
Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci (2000) 3.14
Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet (2007) 3.09
Mitochondria: the next (neurode)generation. Neuron (2011) 3.06
Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J Cell Biol (2003) 2.94
Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet (2008) 2.82
Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neurosci (2009) 2.71
Synaptic energy use and supply. Neuron (2012) 2.40
Proteomics of early zebrafish embryos. BMC Dev Biol (2006) 2.36
Vesicular glycolysis provides on-board energy for fast axonal transport. Cell (2013) 2.33
Neuromuscular synapses can form in vivo by incorporation of initially aneural postsynaptic specializations. Development (2005) 2.30
Motor neuron diversity in development and disease. Annu Rev Neurosci (2010) 2.18
Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum Mol Genet (2002) 2.13
Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. J Mol Diagn (2003) 1.99
Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis (2007) 1.95
Neuronal matrix metalloproteinase-9 is a determinant of selective neurodegeneration. Neuron (2014) 1.90
Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron (2011) 1.85
SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy. Hum Mol Genet (2010) 1.80
Glycolytic Enzymes Localize to Synapses under Energy Stress to Support Synaptic Function. Neuron (2016) 1.65
Synaptic defects in the spinal and neuromuscular circuitry in a mouse model of spinal muscular atrophy. PLoS One (2010) 1.63
Spinal muscular atrophy: going beyond the motor neuron. Trends Mol Med (2012) 1.63
Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy. Hum Mol Genet (2011) 1.61
Regulation of mitochondrial biogenesis. Essays Biochem (2010) 1.58
A computational model of motor neuron degeneration. Neuron (2014) 1.47
Total protein analysis as a reliable loading control for quantitative fluorescent Western blotting. PLoS One (2013) 1.43
Motor neuron mitochondrial dysfunction in spinal muscular atrophy. Hum Mol Genet (2016) 1.41
The SMN complex is associated with snRNPs throughout their cytoplasmic assembly pathway. Mol Cell Biol (2002) 1.39
Childhood spinal muscular atrophy: controversies and challenges. Lancet Neurol (2012) 1.28
Spinal muscular atrophy: the role of SMN in axonal mRNA regulation. Brain Res (2012) 1.26
The survival of motor neuron (SMN) protein interacts with the mRNA-binding protein HuD and regulates localization of poly(A) mRNA in primary motor neuron axons. J Neurosci (2011) 1.25
Synaptic defects in type I spinal muscular atrophy in human development. J Pathol (2013) 1.13
Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy. Eur J Hum Genet (1999) 1.12
Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother (2015) 1.08
Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy. J Clin Invest (2014) 1.08
Regulation of axonal mitochondrial transport and its impact on synaptic transmission. Neurosci Res (2011) 1.06
Structure and expression of the mouse necdin gene. Identification of a postmitotic neuron-restrictive core promoter. J Biol Chem (1996) 1.05
Unravelling the enigma of selective vulnerability in neurodegeneration: motor neurons resistant to degeneration in ALS show distinct gene expression characteristics and decreased susceptibility to excitotoxicity. Acta Neuropathol (2012) 1.05
ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. Hum Mol Genet (2013) 1.04
Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy. J Neurosci Res (2009) 0.99
Density, calibre and ramification of muscle capillaries are altered in a mouse model of severe spinal muscular atrophy. Neuromuscul Disord (2011) 0.98
SMN deficiency alters Nrxn2 expression and splicing in zebrafish and mouse models of spinal muscular atrophy. Hum Mol Genet (2013) 0.98
Temporal requirement for SMN in motoneuron development. Hum Mol Genet (2013) 0.96
Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy. Hum Mol Genet (2013) 0.93
Vascular Defects and Spinal Cord Hypoxia in Spinal Muscular Atrophy. Ann Neurol (2016) 0.90
Motor neurons with differential vulnerability to degeneration show distinct protein signatures in health and ALS. Neuroscience (2015) 0.88
Central presynaptic terminals are enriched in ATP but the majority lack mitochondria. PLoS One (2015) 0.88
Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing. Neuromuscul Disord (2010) 0.86
The spinal muscular atrophy mouse model, SMAΔ7, displays altered axonal transport without global neurofilament alterations. Acta Neuropathol (2011) 0.86
Morphological characteristics of motor neurons do not determine their relative susceptibility to degeneration in a mouse model of severe spinal muscular atrophy. PLoS One (2012) 0.85
Moving towards treatments for spinal muscular atrophy: hopes and limits. Expert Opin Emerg Drugs (2015) 0.85
The Power of Human Protective Modifiers: PLS3 and CORO1C Unravel Impaired Endocytosis in Spinal Muscular Atrophy and Rescue SMA Phenotype. Am J Hum Genet (2016) 0.85
Terazosin activates Pgk1 and Hsp90 to promote stress resistance. Nat Chem Biol (2014) 0.83
Deficiency of the Survival of Motor Neuron Protein Impairs mRNA Localization and Local Translation in the Growth Cone of Motor Neurons. J Neurosci (2016) 0.83
Transcriptional profiling of differentially vulnerable motor neurons at pre-symptomatic stage in the Smn (2b/-) mouse model of spinal muscular atrophy. Acta Neuropathol Commun (2015) 0.83
The identification of a recurrent phosphoglycerate kinase mutation associated with chronic haemolytic anaemia and neurological dysfunction in a family from USA. Br J Haematol (2006) 0.82
Effective heritable gene knockdown in zebrafish using synthetic microRNAs. Nat Commun (2015) 0.82
Two new phosphoglycerate kinase mutations associated with chronic haemolytic anaemia and neurological dysfunction in two patients from Spain. Br J Haematol (2006) 0.82
Selective Motor Neuron Resistance and Recovery in a New Inducible Mouse Model of TDP-43 Proteinopathy. J Neurosci (2016) 0.82
Abnormal mitochondrial transport and morphology as early pathological changes in human models of spinal muscular atrophy. Dis Model Mech (2015) 0.81
Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy. JAMA Neurol (2015) 0.81
Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy. JCI Insight (2016) 0.81
Selective Expression of Osteopontin in ALS-resistant Motor Neurons is a Critical Determinant of Late Phase Neurodegeneration Mediated by Matrix Metalloproteinase-9. Sci Rep (2016) 0.80
Selective loss of alpha motor neurons with sparing of gamma motor neurons and spinal cord cholinergic neurons in a mouse model of spinal muscular atrophy. J Anat (2015) 0.79
Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults. Nat Commun (2016) 0.78
Comparative interactomics analysis of different ALS-associated proteins identifies converging molecular pathways. Acta Neuropathol (2016) 0.78
UBA1: At the Crossroads of Ubiquitin Homeostasis and Neurodegeneration. Trends Mol Med (2015) 0.78
Decreased function of survival motor neuron protein impairs endocytic pathways. Proc Natl Acad Sci U S A (2016) 0.77
Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy. Hum Mol Genet (2016) 0.77
Central and peripheral defects in motor units of the diaphragm of spinal muscular atrophy mice. Mol Cell Neurosci (2015) 0.76
Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis. PLoS One (2016) 0.76
Synaptotagmin-2, and -1, linked to neurotransmission impairment and vulnerability in Spinal Muscular Atrophy. Hum Mol Genet (2016) 0.75
Sideroflexin 3 is a α-synuclein-dependent mitochondrial protein that regulates synaptic morphology. J Cell Sci (2017) 0.75
NMJ-morph reveals principal components of synaptic morphology influencing structure-function relationships at the neuromuscular junction. Open Biol (2016) 0.75
Proteomic mapping of differentially vulnerable pre-synaptic populations identifies regulators of neuronal stability in vivo. Sci Rep (2017) 0.75
Viral delivery of C9ORF72 hexanucleotide repeat expansions in mice lead to repeat length dependent neuropathology and behavioral deficits. Dis Model Mech (2017) 0.75